 | • レポートコード：GIR201105753 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、ネプリライシンの世界市場を調査対象にし、ネプリライシンの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（TD-0714、STR-324、PL-265、LHW-090、その他）、用途別分析（急性心不全、がん性疼痛、高血圧、アルツハイマー病、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Bioprojet SCR、Theravance Biopharma Inc、Novartis AG、Pharmaleads SA ・メーカー別販売量、売上、市場シェア ・ネプリライシンの地域別市場分析 ・ネプリライシンの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・ネプリライシンのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・ネプリライシンのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・ネプリライシンの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・ネプリライシンの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・ネプリライシンの種類別市場規模2015-2020：TD-0714、STR-324、PL-265、LHW-090、その他 ・ネプリライシンの用途別市場規模2015-2020：急性心不全、がん性疼痛、高血圧、アルツハイマー病、その他 ・ネプリライシンの世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Neprilysin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Neprilysin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Neprilysin market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Neprilysin market has been segmented into
TD-0714
STR-324
PL-265
LHW-090
Others
By Application, Neprilysin has been segmented into:
Acute Heart Failure
Cancer Pain
Hypertension
Alzheimer’s Disease
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Neprilysin market presented in the report. This section sheds light on the sales growth of different regional and country-level Neprilysin markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Neprilysin market.
The report offers in-depth assessment of the growth and other aspects of the Neprilysin market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Neprilysin Market Share Analysis
Neprilysin competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Neprilysin sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Neprilysin sales, revenue and market share for each player covered in this report.
The major players covered in Neprilysin are:
Bioprojet SCR
Theravance Biopharma Inc
Novartis AG
Pharmaleads SA
Among other players domestic and global, Neprilysin market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Neprilysin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Neprilysin, with price, sales, revenue and global market share of Neprilysin in 2018 and 2019.
Chapter 3, the Neprilysin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neprilysin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Neprilysin market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Neprilysin sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Neprilysin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Neprilysin Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 TD-0714
1.2.3 STR-324
1.2.4 PL-265
1.2.5 LHW-090
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Neprilysin Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Acute Heart Failure
1.3.3 Cancer Pain
1.3.4 Hypertension
1.3.5 Alzheimer’s Disease
1.3.6 Others
1.4 Overview of Global Neprilysin Market
1.4.1 Global Neprilysin Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bioprojet SCR
2.1.1 Bioprojet SCR Details
2.1.2 Bioprojet SCR Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Bioprojet SCR SWOT Analysis
2.1.4 Bioprojet SCR Product and Services
2.1.5 Bioprojet SCR Neprilysin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Theravance Biopharma Inc
2.2.1 Theravance Biopharma Inc Details
2.2.2 Theravance Biopharma Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Theravance Biopharma Inc SWOT Analysis
2.2.4 Theravance Biopharma Inc Product and Services
2.2.5 Theravance Biopharma Inc Neprilysin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novartis AG
2.3.1 Novartis AG Details
2.3.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Novartis AG SWOT Analysis
2.3.4 Novartis AG Product and Services
2.3.5 Novartis AG Neprilysin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pharmaleads SA
2.4.1 Pharmaleads SA Details
2.4.2 Pharmaleads SA Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pharmaleads SA SWOT Analysis
2.4.4 Pharmaleads SA Product and Services
2.4.5 Pharmaleads SA Neprilysin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Neprilysin Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Neprilysin Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Neprilysin Manufacturer Market Share in 2019
3.3.2 Top 6 Neprilysin Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Neprilysin Sales, Revenue and Market Share by Regions
4.1.1 Global Neprilysin Sales and Market Share by Regions (2015-2020)
4.1.2 Global Neprilysin Revenue and Market Share by Regions (2015-2020)
4.2 North America Neprilysin Sales and Growth Rate (2015-2020)
4.3 Europe Neprilysin Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Neprilysin Sales and Growth Rate (2015-2020)
4.5 South America Neprilysin Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Neprilysin Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Neprilysin Sales, Revenue and Market Share by Country
5.1.1 North America Neprilysin Sales and Market Share by Country (2015-2020)
5.1.2 North America Neprilysin Revenue and Market Share by Country (2015-2020)
5.2 United States Neprilysin Sales and Growth Rate (2015-2020)
5.3 Canada Neprilysin Sales and Growth Rate (2015-2020)
5.4 Mexico Neprilysin Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Neprilysin Sales, Revenue and Market Share by Country
6.1.1 Europe Neprilysin Sales and Market Share by Country (2015-2020)
6.1.2 Europe Neprilysin Revenue and Market Share by Country (2015-2020)
6.2 Germany Neprilysin Sales and Growth Rate (2015-2020)
6.3 UK Neprilysin Sales and Growth Rate (2015-2020)
6.4 France Neprilysin Sales and Growth Rate (2015-2020)
6.5 Russia Neprilysin Sales and Growth Rate (2015-2020)
6.6 Italy Neprilysin Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Neprilysin Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Neprilysin Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Neprilysin Revenue and Market Share by Regions (2015-2020)
7.2 China Neprilysin Sales and Growth Rate (2015-2020)
7.3 Japan Neprilysin Sales and Growth Rate (2015-2020)
7.4 Korea Neprilysin Sales and Growth Rate (2015-2020)
7.5 India Neprilysin Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Neprilysin Sales and Growth Rate (2015-2020)
7.7 Australia Neprilysin Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Neprilysin Sales, Revenue and Market Share by Country
8.1.1 South America Neprilysin Sales and Market Share by Country (2015-2020)
8.1.2 South America Neprilysin Revenue and Market Share by Country (2015-2020)
8.2 Brazil Neprilysin Sales and Growth Rate (2015-2020)
8.3 Argentina Neprilysin Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Neprilysin Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Neprilysin Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Neprilysin Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Neprilysin Sales and Growth Rate (2015-2020)
9.3 Turkey Neprilysin Sales and Growth Rate (2015-2020)
9.4 Egypt Neprilysin Sales and Growth Rate (2015-2020)
9.5 South Africa Neprilysin Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Neprilysin Sales and Market Share by Type (2015-2020)
10.2 Global Neprilysin Revenue and Market Share by Type (2015-2020)
10.3 Global Neprilysin Price by Type (2015-2020)
11 Global Neprilysin Market Segment by Application
11.1 Global Neprilysin Sales Market Share by Application (2015-2020)
11.2 Global Neprilysin Revenue Market Share by Application (2015-2020)
11.3 Global Neprilysin Price by Application (2015-2020)
12 Market Forecast
12.1 Global Neprilysin Sales, Revenue and Growth Rate (2021-2025)
12.2 Neprilysin Market Forecast by Regions (2021-2025)
12.2.1 North America Neprilysin Market Forecast (2021-2025)
12.2.2 Europe Neprilysin Market Forecast (2021-2025)
12.2.3 Asia-Pacific Neprilysin Market Forecast (2021-2025)
12.2.4 South America Neprilysin Market Forecast (2021-2025)
12.2.5 Middle East & Africa Neprilysin Market Forecast (2021-2025)
12.3 Neprilysin Market Forecast by Type (2021-2025)
12.3.1 Global Neprilysin Sales Forecast by Type (2021-2025)
12.3.2 Global Neprilysin Market Share Forecast by Type (2021-2025)
12.4 Neprilysin Market Forecast by Application (2021-2025)
12.4.1 Global Neprilysin Sales Forecast by Application (2021-2025)
12.4.2 Global Neprilysin Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Neprilysin Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Neprilysin by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Neprilysin Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Bioprojet SCR Basic Information, Manufacturing Base and Competitors
Table 8. Bioprojet SCR Neprilysin Major Business
Table 9. Bioprojet SCR Neprilysin Total Revenue (USD Million) (2018-2019)
Table 10. Bioprojet SCR SWOT Analysis
Table 11. Bioprojet SCR Neprilysin Product and Services
Table 12. Bioprojet SCR Neprilysin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Theravance Biopharma Inc Basic Information, Manufacturing Base and Competitors
Table 14. Theravance Biopharma Inc Neprilysin Major Business
Table 15. Theravance Biopharma Inc Neprilysin Total Revenue (USD Million) (2018-2019)
Table 16. Theravance Biopharma Inc SWOT Analysis
Table 17. Theravance Biopharma Inc Neprilysin Product and Services
Table 18. Theravance Biopharma Inc Neprilysin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 20. Novartis AG Neprilysin Major Business
Table 21. Novartis AG Neprilysin Total Revenue (USD Million) (2018-2019)
Table 22. Novartis AG SWOT Analysis
Table 23. Novartis AG Neprilysin Product and Services
Table 24. Novartis AG Neprilysin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Pharmaleads SA Basic Information, Manufacturing Base and Competitors
Table 26. Pharmaleads SA Neprilysin Major Business
Table 27. Pharmaleads SA Neprilysin Total Revenue (USD Million) (2018-2019)
Table 28. Pharmaleads SA SWOT Analysis
Table 29. Pharmaleads SA Neprilysin Product and Services
Table 30. Pharmaleads SA Neprilysin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Global Neprilysin Sales by Manufacturer (2018-2019) (K Pcs)
Table 32. Global Neprilysin Revenue by Manufacturer (2018-2019) (USD Million)
Table 33. Global Neprilysin Sales by Regions (2015-2020) (K Pcs)
Table 34. Global Neprilysin Sales Market Share by Regions (2015-2020)
Table 35. Global Neprilysin Revenue by Regions (2015-2020) (USD Million)
Table 36. North America Neprilysin Sales by Countries (2015-2020) (K Pcs)
Table 37. North America Neprilysin Sales Market Share by Countries (2015-2020)
Table 38. North America Neprilysin Revenue by Countries (2015-2020) (USD Million)
Table 39. North America Neprilysin Revenue Market Share by Countries (2015-2020)
Table 40. Europe Neprilysin Sales by Countries (2015-2020) (K Pcs)
Table 41. Europe Neprilysin Sales Market Share by Countries (2015-2020)
Table 42. Europe Neprilysin Revenue by Countries (2015-2020) (USD Million)
Table 43. Asia-Pacific Neprilysin Sales by Regions (2015-2020) (K Pcs)
Table 44. Asia-Pacific Neprilysin Sales Market Share by Regions (2015-2020)
Table 45. Asia-Pacific Neprilysin Revenue by Regions (2015-2020) (USD Million)
Table 46. South America Neprilysin Sales by Countries (2015-2020) (K Pcs)
Table 47. South America Neprilysin Sales Market Share by Countries (2015-2020)
Table 48. South America Neprilysin Revenue by Countries (2015-2020) (USD Million)
Table 49. South America Neprilysin Revenue Market Share by Countries (2015-2020)
Table 50. Middle East & Africa Neprilysin Sales by Countries (2015-2020) (K Pcs)
Table 51. Middle East & Africa Neprilysin Sales Market Share by Countries (2015-2020)
Table 52. Middle East & Africa Neprilysin Revenue by Countries (2015-2020) (USD Million)
Table 53. Middle East & Africa Neprilysin Revenue Market Share by Countries (2015-2020)
Table 54. Global Neprilysin Sales by Type (2015-2020) (K Pcs)
Table 55. Global Neprilysin Sales Share by Type (2015-2020)
Table 56. Global Neprilysin Revenue by Type (2015-2020) (USD Million)
Table 57. Global Neprilysin Revenue Share by Type (2015-2020)
Table 58. Global Neprilysin Sales by Application (2015-2020) (K Pcs)
Table 59. Global Neprilysin Sales Share by Application (2015-2020)
Table 60. Global Neprilysin Sales Forecast by Regions (2021-2025) (K Pcs)
Table 61. Global Neprilysin Market Share Forecast by Regions (2021-2025)
Table 62. Global Neprilysin Sales Forecast by Type (2021-2025) (K Pcs)
Table 63. Global Neprilysin Market Share Forecast by Type (2021-2025)
Table 64. Global Neprilysin Sales Forecast by Application (2021-2025)
Table 65. Global Neprilysin Market Share Forecast by Application (2021-2025)
Table 66. Direct Channel Pros & Cons
Table 67. Indirect Channel Pros & Cons
Table 68. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Neprilysin Picture
Figure 2. Global Sales Market Share of Neprilysin by Type in 2019
Figure 3. TD-0714 Picture
Figure 4. STR-324 Picture
Figure 5. PL-265 Picture
Figure 6. LHW-090 Picture
Figure 7. Others Picture
Figure 8. Neprilysin Sales Market Share by Application in 2018
Figure 9. Acute Heart Failure Picture
Figure 10. Cancer Pain Picture
Figure 11. Hypertension Picture
Figure 12. Alzheimer's Disease Picture
Figure 13. Others Picture
Figure 14. Global Neprilysin Market Status and Outlook (2015-2025) (USD Million)
Figure 15. United States Neprilysin Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Canada Neprilysin Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Mexico Neprilysin Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Germany Neprilysin Revenue (Value) and Growth Rate (2015-2025)
Figure 19. France Neprilysin Revenue (Value) and Growth Rate (2015-2025)
Figure 20. UK Neprilysin Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Russia Neprilysin Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Italy Neprilysin Revenue (Value) and Growth Rate (2015-2025)
Figure 23. China Neprilysin Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Japan Neprilysin Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Korea Neprilysin Revenue (Value) and Growth Rate (2015-2025)
Figure 26. India Neprilysin Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Southeast Asia Neprilysin Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Australia Neprilysin Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 29. Brazil Neprilysin Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Egypt Neprilysin Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Saudi Arabia Neprilysin Revenue (Value) and Growth Rate (2015-2025)
Figure 32. South Africa Neprilysin Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Turkey Neprilysin Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Global Neprilysin Sales Market Share by Manufacturer in 2019
Figure 35. Global Neprilysin Revenue Market Share by Manufacturer in 2019
Figure 36. Top 3 Neprilysin Manufacturer (Revenue) Market Share in 2019
Figure 37. Top 6 Neprilysin Manufacturer (Revenue) Market Share in 2019
Figure 38. Key Manufacturer Market Share Trend
Figure 39. Global Neprilysin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 40. Global Neprilysin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 41. Global Neprilysin Revenue Market Share by Regions (2015-2020)
Figure 42. Global Neprilysin Revenue Market Share by Regions in 2018
Figure 43. North America Neprilysin Sales and Growth Rate (2015-2020)
Figure 44. Europe Neprilysin Sales and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Neprilysin Sales and Growth Rate (2015-2020)
Figure 46. South America Neprilysin Sales and Growth Rate (2015-2020)
Figure 47. Middle East & Africa Neprilysin Sales and Growth Rate (2015-2020)
Figure 48. North America Neprilysin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 49. North America Neprilysin Sales Market Share by Countries (2015-2020)
Figure 50. North America Neprilysin Sales Market Share by Countries in 2018
Figure 51. North America Neprilysin Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 52. North America Neprilysin Revenue Market Share by Countries in 2018
Figure 53. United States Neprilysin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Canada Neprilysin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. Mexico Neprilysin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. Europe Neprilysin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 57. Europe Neprilysin Revenue Market Share by Countries (2015-2020)
Figure 58. Europe Neprilysin Revenue Market Share by Countries in 2019
Figure 59. Germany Neprilysin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. UK Neprilysin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. France Neprilysin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Russia Neprilysin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Italy Neprilysin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Asia-Pacific Neprilysin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 65. Asia-Pacific Neprilysin Sales Market Share by Regions 2019
Figure 66. Asia-Pacific Neprilysin Revenue Market Share by Regions 2019
Figure 67. China Neprilysin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Japan Neprilysin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Korea Neprilysin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. India Neprilysin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. Southeast Asia Neprilysin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. South America Neprilysin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. South America Neprilysin Sales Market Share by Countries in 2019
Figure 74. South America Neprilysin Revenue Market Share by Countries in 2019
Figure 75. Brazil Neprilysin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 76. Argentina Neprilysin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 77. Middle East and Africa Neprilysin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. Middle East and Africa Neprilysin Sales Market Share by Countries in 2019
Figure 79. Middle East and Africa Neprilysin Revenue Market Share by Countries (2015-2020)
Figure 80. Middle East and Africa Neprilysin Revenue Market Share by Countries in 2019
Figure 81. Saudi Arabia Neprilysin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Egypt Neprilysin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Turkey Neprilysin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. South Africa Neprilysin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 85. Global Neprilysin Sales and Growth Rate (2021-2025) (K Pcs)
Figure 86. Global Neprilysin Revenue and Growth Rate (2021-2025) (USD Million)
Figure 87. North America Sales Neprilysin Market Forecast (2021-2025) (K Pcs)
Figure 88. Europe Sales Neprilysin Market Forecast (2021-2025) (K Pcs)
Figure 89. Asia-Pacific Sales Neprilysin Market Forecast (2021-2025) (K Pcs)
Figure 90. South America Sales Neprilysin Market Forecast (2021-2025) (K Pcs)
Figure 91. Middle East & Africa Sales Neprilysin Market Forecast (2021-2025) (K Pcs)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel
アルツハイマー病治療薬の世界市場 2020年 Market Overview The Alzheimer's Disease Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…- アルツハイマー病治療の世界市場 2020年 Market Overview The global Alzheimer's Disease Treatments market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Alzheimer's Di…
- 心臓肺マシンの世界市場 2020年 Market Overview The Heart Lung Machine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- 故障解析の世界市場 2020年 Market Overview The global Failure Analysis market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Failure Analysis market repo…
- マイトジェン活性化プロテインキナーゼ8の世界市場 2020年 Market Overview The global Mitogen Activated Protein Kinase 8 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Mitogen Ac…